← 전체 보충제 목록

칼륨 (시트레이트)

Potassium (Citrate)

📑 PubMed 32편 ⚗️ 미네랄

📚 관련 논문 (30편)

1.
Effect of potassium citrate supplement on stone recurrence before or after lithotripsy: systematic review and meta-analysis.
Urolithiasis 2017 PMID:27915395

1. Urolithiasis. 2017 Oct;45(5):449-455. doi: 10.1007/s00240-016-0950-1. Epub 2016 Dec 3. Effect of potassium citrate supplement on stone recurrence before or after lithotripsy: systematic review and meta-analysis. Carvalho M(1)(2), Erbano BO(3), Kuwaki EY(1), Pontes HP(1), Liu JWTW(1), Boros L

2.
The effect of supplementation with alkaline potassium salts on bone metabolism: a meta-analysis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015 PMID:25572045

2. Osteoporos Int. 2015 Apr;26(4):1311-8. doi: 10.1007/s00198-014-3006-9. Epub 2015 Jan 9. The effect of supplementation with alkaline potassium salts on bone metabolism: a meta-analysis. Lambert H(1), Frassetto L, Moore JB, Torgerson D, Gannon R, Burckhardt P, Lanham-New S. Author information

3.
Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial.
Helicobacter 2026 PMID:41645038

3. Helicobacter. 2026 Jan-Feb;31(1):e70100. doi: 10.1111/hel.70100. Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial. Wei S(1), Huang Z(2), Xiong H(1), Wu J(3), Mei D(3), Zhao J(4), Liu

4.
Beneficial effects of a compound probiotic in Helicobacter pylori-infected patients aged over 40 years: An open-label randomised clinical trial.
International journal of antimicrobial agents 2026 PMID:41520709

4. Int J Antimicrob Agents. 2026 Mar;67(3):107712. doi: 10.1016/j.ijantimicag.2026.107712. Epub 2026 Jan 9. Beneficial effects of a compound probiotic in Helicobacter pylori-infected patients aged over 40 years: An open-label randomised clinical trial. Yang C(1), Cheng J(2), Zhang M(3), Lu B(1),

5.
Lime-based supplement reduces calcium oxalate stone recurrence: A multicenter randomized controlled trial.
PloS one 2025 PMID:41348736

5. PLoS One. 2025 Dec 5;20(12):e0336892. doi: 10.1371/journal.pone.0336892. eCollection 2025. Lime-based supplement reduces calcium oxalate stone recurrence: A multicenter randomized controlled trial. Dissayabutra T(1)(2), Anegkamol W(1), Ratchanon S(3), Ungjaroenwathana W(4), Klinhom T(4), Sas

6.
Natriuretic response to an acute oral potassium load in healthy individuals and patients with chronic kidney disease: a randomized controlled trial.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026 PMID:41288308

6. Nephrol Dial Transplant. 2026 Jan 30;41(2):255-264. doi: 10.1093/ndt/gfaf238. Natriuretic response to an acute oral potassium load in healthy individuals and patients with chronic kidney disease: a randomized controlled trial. Wouda RD(1), Karsten M(1), Michels EHA(1), Garrelds IM(2), Danser A

7.
Effect of low-potential renal acid load diet intervention on urinary lithogenic parameters in recurrent calcium urolithiasis patients (A Preliminary Randomized Controlled Trial).
Urolithiasis 2025 PMID:41251791

7. Urolithiasis. 2025 Nov 18;53(1):221. doi: 10.1007/s00240-025-01895-x. Effect of low-potential renal acid load diet intervention on urinary lithogenic parameters in recurrent calcium urolithiasis patients (A Preliminary Randomized Controlled Trial). Li P(1), Yang X(1), Lang Y(1), Zhou Y(1), Fa

8.
Different Doses of Ilaprazole for Dual Therapy Versus Bismuth-Quadruple Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial.
Helicobacter 2025 PMID:41211681

8. Helicobacter. 2025 Nov-Dec;30(6):e70086. doi: 10.1111/hel.70086. Different Doses of Ilaprazole for Dual Therapy Versus Bismuth-Quadruple Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial. Han Q(1), Zu M(2), Du S(3), Guo Y(4), Zhu Y(5), Wang Y(1), Liu X(1), Guo H

9.
Tailored Therapy Guided by Antibiotic Genotypic Resistances and CYP2C19 Polymorphisms Detected From Fecal Specimens for the First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial.
Helicobacter 2025 PMID:41116602

9. Helicobacter. 2025 Sep-Oct;30(5):e70082. doi: 10.1111/hel.70082. Tailored Therapy Guided by Antibiotic Genotypic Resistances and CYP2C19 Polymorphisms Detected From Fecal Specimens for the First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial. Suo B(1), Ren X(1), Li C(1),

10.
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial.
The Lancet. Infectious diseases 2026 PMID:40945526

10. Lancet Infect Dis. 2026 Jan;26(1):101-110. doi: 10.1016/S1473-3099(25)00438-4. Epub 2025 Sep 10. Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre,

11.
Randomized multicenter trial comparing minocycline and ornidazole with classical quadruple therapy in Helicobacter pylori treatment.
Scientific reports 2025 PMID:40348820

11. Sci Rep. 2025 May 10;15(1):16318. doi: 10.1038/s41598-025-01117-9. Randomized multicenter trial comparing minocycline and ornidazole with classical quadruple therapy in Helicobacter pylori treatment. Lin Y(1)(2)(3), Lin X(1)(2)(3), Suo B(4), Chen Q(4), Cheng X(5), Lin Z(1)(2)(3), Huang X(6)(

12.
Seven-Day Versus 14-Day Tegoprazan and Tetracycline-Containing Quadruple Therapy for First-Line Eradication of Helicobacter pylori Infection: A Randomized, Open-Label, Noninferiority Trial.
Helicobacter 2025 PMID:40272011

12. Helicobacter. 2025 Mar-Apr;30(2):e70036. doi: 10.1111/hel.70036. Seven-Day Versus 14-Day Tegoprazan and Tetracycline-Containing Quadruple Therapy for First-Line Eradication of Helicobacter pylori Infection: A Randomized, Open-Label, Noninferiority Trial. Nan XP(1)(2)(3), Zhao HY(1)(2)(3)(4),

13.
In vitro anti-Helicobacter pylori activity of ilaprazole used alone and in combination with other components of quadruple therapy.
Microbiology spectrum 2025 PMID:40990560

13. Microbiol Spectr. 2025 Nov 4;13(11):e0059325. doi: 10.1128/spectrum.00593-25. Epub 2025 Sep 24. In vitro anti-Helicobacter pylori activity of ilaprazole used alone and in combination with other components of quadruple therapy. Zhang Z(#)(1)(2), Yang L(#)(3), Sun W(#)(3), Hu X(1)(2), Nie T(1)

14.
Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial.
Clinical drug investigation 2024 PMID:38615091

14. Clin Drug Investig. 2024 May;44(5):343-355. doi: 10.1007/s40261-024-01359-x. Epub 2024 Apr 13. Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Contr

15.
Neutralization of Acidic Tumor Microenvironment (TME) with Daily Oral Dosing of Sodium Potassium Citrate (K/Na Citrate) Increases Therapeutic Effect of Anti-cancer Agent in Pancreatic Cancer Xenograft Mice Model.
Biological & pharmaceutical bulletin 2021 PMID:33518679

15. Biol Pharm Bull. 2021;44(2):266-270. doi: 10.1248/bpb.b20-00825. Neutralization of Acidic Tumor Microenvironment (TME) with Daily Oral Dosing of Sodium Potassium Citrate (K/Na Citrate) Increases Therapeutic Effect of Anti-cancer Agent in Pancreatic Cancer Xenograft Mice Model. Ando H(1), Esh

16.
Inhibitory effects of taraxasterol and aqueous extract of Taraxacum officinale on calcium oxalate crystallization: in vitro study.
Renal failure 2018 PMID:29619876

19. Ren Fail. 2018 Nov;40(1):298-305. doi: 10.1080/0886022X.2018.1455595. Inhibitory effects of taraxasterol and aqueous extract of Taraxacum officinale on calcium oxalate crystallization: in vitro study. Yousefi Ghale-Salimi M(1), Eidi M(2), Ghaemi N(3), Khavari-Nejad RA(1). Author information:

17.
Aluminum citrate inhibits cytotoxicity and aggregation of oxalate crystals.
Toxicology 2007 PMID:17161516

10. Toxicology. 2007 Feb 12;230(2-3):117-25. doi: 10.1016/j.tox.2006.11.046. Epub 2006 Nov 15. Aluminum citrate inhibits cytotoxicity and aggregation of oxalate crystals. Guo C(1), McMartin KE. Author information: (1)Department of Pharmacology, Toxicology & Neuroscience, Louisiana State Univers

18.
Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
Urology 2004 PMID:14751336

28. Urology. 2004 Jan;63(1):7-11; discussion 11-2. doi: 10.1016/j.urology.2003.09.057. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Kato Y(1), Yamaguchi S, Yachiku S, Nakazono S, Hori J, Wada N, Hou K. Author in

19.
Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics.
The Journal of antimicrobial chemotherapy 1991 PMID:1663108

17. J Antimicrob Chemother. 1991 Jul;28(1):87-94. doi: 10.1093/jac/28.1.87. Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics. Akerele JO(1), Okhamafe AO. Author information: (1)Department of Pharmaceutical Microbiology, University of Benin, Nigeria. Following recent

20.
Effect of bismuth subcarbonate against Campylobacter pylori: do citrate ions improve antibacterial activity?
Zentralblatt fur Bakteriologie : international journal of medical microbiology 1990 PMID:2363796

46. Zentralbl Bakteriol. 1990 May;273(1):33-5. doi: 10.1016/s0934-8840(11)80237-9. Effect of bismuth subcarbonate against Campylobacter pylori: do citrate ions improve antibacterial activity? Vogt K(1), Warrelmann M, Hahn H. Author information: (1)Institut für Medizinische Mikrobiologie, Freien

21.
Triamterene-induced crystalluria and cylinduria: clinical and experimental studies.
Clinical nephrology 1986 PMID:3780069

37. Clin Nephrol. 1986 Oct;26(4):169-73. Triamterene-induced crystalluria and cylinduria: clinical and experimental studies. Fairley KF, Woo KT, Birch DF, Leaker BR, Ratnaike S. We examined the occurrence of crystals and casts in the urine of healthy subjects after administration of triamterene

22.
Inhibition of multiplication of tobacco mosaic virus in protoplasts by antibiotics and its prevention by divalent metals.
The Journal of general virology 1975 PMID:1176964

33. J Gen Virol. 1975 Aug;28(2):185-91. doi: 10.1099/0022-1317-28-2-185. Inhibition of multiplication of tobacco mosaic virus in protoplasts by antibiotics and its prevention by divalent metals. Kassanis B, White RF, Woods RD. At concentrations that inhibit bacterial growth, some antibiotics inc

23.
A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment.
The Southeast Asian journal of tropical medicine and public health 2001 PMID:11944733

9. Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):654-60. A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Premgamone A(1), Sriboonlue P, Disatapornjaroen W, Maskasem S, Sinsupan N, Apinives C. Auth

24.
Effect of parathyroidectomy on stone recurrence in primary hyperparathyroidism : A systematic review.
Wiener klinische Wochenschrift 2026 PMID:41874646

38. Wien Klin Wochenschr. 2026 Apr;138(7-8):225-231. doi: 10.1007/s00508-026-02733-9. Epub 2026 Mar 24. Effect of parathyroidectomy on stone recurrence in primary hyperparathyroidism : A systematic review. Jahrreiss V(1), Yurdakul O(1), Veser J(1), Seitz C(2). Author information: (1)Department

25.
Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.
Minerva urology and nephrology 2025 PMID:40891477

43. Minerva Urol Nephrol. 2025 Aug;77(4):472-478. doi: 10.23736/S2724-6051.25.06296-2. Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials. Veronese N(1), Ciriminna S(2), Errera CM(2), Garlisi MC(2), Tulone O(2), Sapienza V(2),

26.
Systematic Review and Meta-Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori.
Helicobacter 2024 PMID:39385325

48. Helicobacter. 2024 Sep-Oct;29(5):e13141. doi: 10.1111/hel.13141. Systematic Review and Meta-Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori. Reum Choe A(1), Tae CH(1), Choi M(2), Shim KN(1), Jung HK(1). Author information: (1)Department of Internal Medicine, Ew

27.
Outcomes of Paediatric Cystine Stone Management: Results of a Systematic Review.
Current urology reports 2023 PMID:37079195

46. Curr Urol Rep. 2023 Aug;24(8):371-380. doi: 10.1007/s11934-023-01162-9. Epub 2023 Apr 20. Outcomes of Paediatric Cystine Stone Management: Results of a Systematic Review. Ripa F(1), Pietropaolo A(1), Geraghty R(2), Griffin S(1), Cook P(3), Somani B(4). Author information: (1)Department of U

28.
Dietary management of hypocitraturia in children with urolithiasis: results from a systematic review.
World journal of urology 2023 PMID:36645461

35. World J Urol. 2023 May;41(5):1243-1250. doi: 10.1007/s00345-023-04282-6. Epub 2023 Jan 16. Dietary management of hypocitraturia in children with urolithiasis: results from a systematic review. Castellani D(1)(2), Giulioni C(3), De Stefano V(3), Brocca C(3), Fuligni D(3), Galosi AB(4)(3), Te

29.
Cystinuria: clinical practice recommendation.
Kidney international 2021 PMID:32918941

38. Kidney Int. 2021 Jan;99(1):48-58. doi: 10.1016/j.kint.2020.06.035. Epub 2020 Sep 9. Cystinuria: clinical practice recommendation. Servais A(1), Thomas K(2), Dello Strologo L(3), Sayer JA(4), Bekri S(5), Bertholet-Thomas A(6), Bultitude M(2), Capolongo G(7), Cerkauskiene R(8), Daudon M(9), D

30.
Medical and dietary interventions for preventing recurrent urinary stones in children.
The Cochrane database of systematic reviews 2017 PMID:29117629

1. Cochrane Database Syst Rev. 2017 Nov 9;11(11):CD011252. doi: 10.1002/14651858.CD011252.pub2. Medical and dietary interventions for preventing recurrent urinary stones in children. Kern A(1), Grimsby G, Mayo H, Baker LA. Author information: (1)Anne Arundel Medical Center, Annapolis, MD, USA.

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.